Clinical Trials Logo

Lyell Syndrome clinical trials

View clinical trials related to Lyell Syndrome.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05520086 Active, not recruiting - Clinical trials for Stevens-Johnson Syndrome

Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.

CELOPHIN
Start date: November 11, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

A phase IIa, open label, non controlled clinical trial to assess the feasibility and safety of allogeneic adipose-derived mesenchymal stem cells (ASC) in the treatment of cicatricial conjunctivitis associated with Lyell's syndrome, Stevens-Johnson's syndrome and mucous membrane pemphigoid with ocular involvement